Polydopamine (PDA) is well-known as the first material-independent adhesive, which firmly attaches to various substances, even hydrophobic materials, through strong coordinative interactions between the phenolic hydroxyl groups of PDA and the substances. In contrast, oil-infused materials such as selflubricating gels (SLUGs) exhibit excellent antiadhesive properties against viscous liquids, ice/snow, (bio)fouling, and so on. In this study, we simply questioned: "What will happen when these two materials with contrary nature meet"? To answer this, we formed a PDA layer on a SLUG surface that exhibits thermoresponsive syneretic properties (release of liquid from the gel matrix to the outer surface) and investigated its interfacial behavior. The oil layer caused by syneresis from the SLUGs at −20 °C was found to show resistance to adhesion of universally adhesive PDA.
Recently, emerging functions utilizing phenolic molecules, such as surface functionalizing agents or bioadhesives, have attracted significant interest. However, the most important role of phenolic compounds is to produce carbonized plant matter called “coal”, which is widely used as an energy source in nearly all countries. Coalification is a long‐term, high‐temperature process in which phenols are converted into conducting carbonized matter. This study focuses on mimicking coalification processes to create conducting sealants from non‐conducting phenolic compounds by heat treatment. We demonstrate that a phenolic adhesive, tri‐hydroxybenzene (known as pyrogallol), and polyethylenimine mixture initially acts as an adhesive sealant that can be converted to a conducting carbon sealing material. The conductivity of the phenolic sealant is about 850 Ω−1 cm−1, which is an approximately two‐fold enhancement of the performance of carbon matter. Applications of the biomimetic adhesives described herein include conducting defect sealants in carbon nanomaterials and conducting binders for metal/carbon or ceramic/carbon composites.
We aimed to investigate the prognostic factors for, and treatment efficacy of, intense pulsed light (IPL) treatment with a vascular filter in patients with moderate or severe meibomian gland dysfunction (MGD). In this retrospective observational study, 58 moderate or severe MGD patients who underwent IPL treatment with a vascular filter were enrolled. IPL treatment was administered to the upper and lower eyelids four times at two-week intervals. At baseline, and four weeks after IPL, we evaluated the matrix metalloproteinase (MMP)-9 expression levels, tear break-up times (TBUT), ocular surface staining scores, lid margin telangiectasias, and meibomian gland characteristics. The subjective symptoms and adverse effects were reviewed and recorded. Regression analyses were performed to explore the prognostic factors affecting clinical outcomes. IPL treatment using a vascular filter led to improvements in the TBUT, ocular surface staining score, meibomian gland grade, meibum quality and consistency, lid margin telangiectasia, and symptom score (all p < 0.001). Furthermore, the positivity rate (90.2% to 70.6%, p = 0.013) and expression levels (1.92 ± 1.18 to 1.24 ± 1.18, p < 0.001) of tear MMP-9 improved after the IPL treatment. In multivariate logistic regression analysis, a young age (odds ratio = 0.867, p = 0.007) and a toothpaste-like consistency in the upper lid (odds ratio = 8.449, p = 0.046) were associated with improvements in the meibomian gland grade. No adverse effects were detected. IPL with a vascular filter is a safe and effective treatment for moderate and severe MGD. Age and the meibum consistency in the upper lid are important prognostic factors.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.